BRPI0715728A8 - tratamento de distúrbios cartilaginosos - Google Patents

tratamento de distúrbios cartilaginosos

Info

Publication number
BRPI0715728A8
BRPI0715728A8 BRPI0715728A BRPI0715728A BRPI0715728A8 BR PI0715728 A8 BRPI0715728 A8 BR PI0715728A8 BR PI0715728 A BRPI0715728 A BR PI0715728A BR PI0715728 A BRPI0715728 A BR PI0715728A BR PI0715728 A8 BRPI0715728 A8 BR PI0715728A8
Authority
BR
Brazil
Prior art keywords
treatment
cartilage disorders
cartilage
disorders
Prior art date
Application number
BRPI0715728A
Other languages
English (en)
Inventor
Gimona Alberto
H Ladel Christoph
Vom Baur Elmar
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2007/058830 external-priority patent/WO2008023063A2/en
Publication of BRPI0715728A2 publication Critical patent/BRPI0715728A2/pt
Publication of BRPI0715728A8 publication Critical patent/BRPI0715728A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0715728A 2006-08-25 2007-08-24 tratamento de distúrbios cartilaginosos BRPI0715728A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (2)

Publication Number Publication Date
BRPI0715728A2 BRPI0715728A2 (pt) 2013-09-17
BRPI0715728A8 true BRPI0715728A8 (pt) 2018-04-03

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715728A BRPI0715728A8 (pt) 2006-08-25 2007-08-24 tratamento de distúrbios cartilaginosos

Country Status (11)

Country Link
CN (1) CN101505787B (pt)
BR (1) BRPI0715728A8 (pt)
DK (1) DK2054050T3 (pt)
ES (1) ES2392883T3 (pt)
MY (1) MY148277A (pt)
NZ (1) NZ574216A (pt)
PT (1) PT2054050E (pt)
RS (1) RS52710B (pt)
SI (1) SI2054050T1 (pt)
UA (1) UA99818C2 (pt)
ZA (1) ZA200900426B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2880179B1 (en) * 2012-08-06 2017-12-13 Merck Patent GmbH Genetic markers for predicting responsiveness to fgf-18 compound
HRP20181570T1 (hr) * 2014-02-20 2018-11-30 Merck Patent Gmbh Režim doziranja spoja fgf-18
KR102437057B1 (ko) * 2014-02-20 2022-08-26 메르크 파텐트 게엠베하 이식편 이식 및 조직 공학 절차에 있어서의 fgf-18
ES2698117T3 (es) * 2014-02-20 2019-01-31 Merck Patent Gmbh Implante que comprende FGF-18
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
US11020454B2 (en) 2015-07-15 2021-06-01 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusion polypeptides and methods of use
CA2994638A1 (en) * 2015-08-13 2017-02-16 Merck Patent Gmbh Combination composition comprising fgf-18 compound
WO2020263989A1 (en) 2019-06-24 2020-12-30 University Of Iowa Research Foundation Jnk inhibitors as anticancer agents
EP4061836A4 (en) * 2019-11-21 2024-02-14 Remedium Bio, Inc. GROWTH FACTOR RESTORATION
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1551426B1 (en) * 2002-10-07 2014-06-25 ZymoGenetics, Inc. Methods of administering fgf18
WO2006014444A1 (en) * 2004-07-06 2006-02-09 Zymogenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
DK1828239T3 (da) * 2004-12-10 2011-12-19 Zymogenetics Inc FGF18-produktion i prokaryote værter

Also Published As

Publication number Publication date
CN101505787B (zh) 2013-09-04
BRPI0715728A2 (pt) 2013-09-17
ES2392883T3 (es) 2012-12-14
ZA200900426B (en) 2010-04-28
PT2054050E (pt) 2012-09-17
CN101505787A (zh) 2009-08-12
MY148277A (en) 2013-03-29
RS52710B (sr) 2013-08-30
SI2054050T1 (sl) 2012-12-31
UA99818C2 (ru) 2012-10-10
DK2054050T3 (da) 2012-09-03
NZ574216A (en) 2011-11-25

Similar Documents

Publication Publication Date Title
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
PL2054050T3 (pl) Leczenie zaburzeń chrząstki z zastosowaniem FGF-18
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
EP1982660A4 (en) TREATMENT ENDOSCOPE
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
IL230335A (en) A drug used to treat cartilage disease
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
PT2046324T (pt) Tratamento e prevenção de mucosite por derivados de antocianidina
CR10562A (es) Nuevos derivados de piridazina
BRPI0716466A2 (pt) Tratamento da calda de açúcar
IL198488A0 (en) Treatment of pervasive developmental disorders
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
BRPI0715728A2 (pt) tratamento de distérbio cartilaginosos
DK2173831T3 (da) Brøndbehandling
DK2056858T3 (da) Behandling af lungesygdomstilstande
EP2446018A4 (en) HEAT-TREATED LIMULUS AMEBOCYTE LYSATES
DE602007013310D1 (de) Hochfrequenzbehandlungsinstrument
BRPI0715087A2 (pt) Método de tratamento de disfunção termoregulatória com paroxetina
EP2013346A4 (en) Pestivirus SPECIES
DK1940447T3 (da) Behandling af neurodegenrative lidelser
FR2896995B1 (fr) Raquette de paddleball
DE602007003350D1 (de) Behandlung von polysilazan-abfall

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]